Literature DB >> 10233995

Influenza A virus RNA polymerase has the ability to stutter at the polyadenylation site of a viral RNA template during RNA replication.

H Zheng1, H A Lee, P Palese, A García-Sastre.   

Abstract

The viral polymerase of influenza virus, a negative-strand RNA virus, is believed to polyadenylate the mRNAs by stuttering at a stretch of five to seven uridine residues which are located close to the 5' ends of the viral RNA templates. However, a mechanism of polyadenylation based on a template-independent synthesis of the poly(A) tail has not been excluded. In this report, we present new evidence showing the inherent ability of the viral polymerase to stutter at the poly(U) stretch of a viral RNA template during RNA replication. Variants which possess 1- to 13-nucleotide-long insertions at the poly(U) stretch have been identified. These results support a stuttering mechanism for the polyadenylation of influenza virus mRNAs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233995      PMCID: PMC112577     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  In vivo analysis of the promoter structure of the influenza virus RNA genome using a transfection system with an engineered RNA.

Authors:  K Yamanaka; N Ogasawara; H Yoshikawa; A Ishihama; K Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

2.  The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure.

Authors:  G X Luo; W Luytjes; M Enami; P Palese
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

3.  A new method for reconstituting influenza polymerase and RNA in vitro: a study of the promoter elements for cRNA and vRNA synthesis in vitro and viral rescue in vivo.

Authors:  B L Seong; G G Brownlee
Journal:  Virology       Date:  1992-01       Impact factor: 3.616

4.  Amplification, expression, and packaging of foreign gene by influenza virus.

Authors:  W Luytjes; M Krystal; M Enami; J D Parvin; P Palese
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

Review 5.  Genetic manipulation of negative-strand RNA virus genomes.

Authors:  A García-Sastre; P Palese
Journal:  Annu Rev Microbiol       Date:  1993       Impact factor: 15.500

6.  Mutational analysis of the influenza virus vRNA promoter.

Authors:  M E Piccone; A Fernandez-Sesma; P Palese
Journal:  Virus Res       Date:  1993-05       Impact factor: 3.303

7.  Polyadenylation sites for influenza virus mRNA.

Authors:  J S Robertson; M Schubert; R A Lazzarini
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

8.  High-efficiency formation of influenza virus transfectants.

Authors:  M Enami; P Palese
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

9.  Characterization of the polyadenylation signal of influenza virus RNA.

Authors:  X Li; P Palese
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

10.  Two nucleotides immediately upstream of the essential A6G3 slippery sequence modulate the pattern of G insertions during Sendai virus mRNA editing.

Authors:  S Hausmann; D Garcin; A S Morel; D Kolakofsky
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more
  23 in total

1.  Efficient in vitro system of homologous recombination in brome mosaic bromovirus.

Authors:  Rafal Wierzchoslawski; Jozef J Bujarski
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  The genome length of human parainfluenza virus type 2 follows the rule of six, and recombinant viruses recovered from non-polyhexameric-length antigenomic cDNAs contain a biased distribution of correcting mutations.

Authors:  Mario H Skiadopoulos; Leatrice Vogel; Jeffrey M Riggs; Sonja R Surman; Peter L Collins; Brian R Murphy
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Functional analysis of PA binding by influenza a virus PB1: effects on polymerase activity and viral infectivity.

Authors:  D R Perez; R O Donis
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  Repair and polyadenylation of a naturally occurring hepatitis C virus 3' nontranslated region-shorter variant in selectable replicon cell lines.

Authors:  Hans C van Leeuwen; Jolanda M P Liefhebber; Willy J M Spaan
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

5.  Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor.

Authors:  Stephen W Mason; Carol Lawetz; Yvon Gaudette; Florence Dô; Erika Scouten; Lisette Lagacé; Bruno Simoneau; Michel Liuzzi
Journal:  Nucleic Acids Res       Date:  2004-09-08       Impact factor: 16.971

6.  Novel gene product of Thogoto virus segment 6 codes for an interferon antagonist.

Authors:  Kathrin Hagmaier; Stephanie Jennings; Johanna Buse; Friedemann Weber; Georg Kochs
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

7.  Multiple anti-interferon actions of the influenza A virus NS1 protein.

Authors:  Georg Kochs; Adolfo García-Sastre; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

8.  Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs.

Authors:  Shu-Chuan Chen; King-Song Jeng; Michael M C Lai
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

9.  Structural insight into the essential PB1-PB2 subunit contact of the influenza virus RNA polymerase.

Authors:  Kanako Sugiyama; Eiji Obayashi; Atsushi Kawaguchi; Yukari Suzuki; Jeremy R H Tame; Kyosuke Nagata; Sam-Yong Park
Journal:  EMBO J       Date:  2009-05-21       Impact factor: 11.598

10.  Segment-specific kinetics of mRNA, cRNA and vRNA accumulation during influenza infection.

Authors:  Thu Phan; Elizabeth J Fay; Zion Lee; Stephanie Aron; Wei-Shou Hu; Ryan A Langlois
Journal:  J Virol       Date:  2021-03-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.